The Alzheimer’s Therapeutic Research Institute (ATRI) at USC is at the forefront of bringing effective new treatments for Alzheimer’s disease to the world through rigorous clinical trial design and the identification of reliable biomarkers for early detection of the disease – long before cognitive decline occurs.
Learn more about our Alzheimer's research at the Keck School of Medicine of USC: keck.usc.edu/alzheimers
